FDA GFI, Drug and Biologiacal Products that Contain Nanomaterial, 04/22 Beatrice Burtsov2022-11-09T10:28:26+00:00November 9th, 2022|
ICH Guideline, Analytical Procedure Development, Q14, DRAFT, 04/22 Beatrice Burtsov2022-11-08T13:14:37+00:00November 8th, 2022|
ICH Guideline, Analytical Procedure Development, DRAFT, 03/22 Beatrice Burtsov2022-09-07T10:39:12+00:00September 7th, 2022|
ICH Guideline, Validation of Analytical Procedures, R2 DRAFT, 03/22 Beatrice Burtsov2022-10-05T15:26:37+00:00April 5th, 2022|
FDA GFI, Q&A on Quality Related Controlled Correspondance, 09/21 Beatrice Burtsov2022-01-27T12:28:46+00:00January 27th, 2022|
